000 02409 a2200697 4500
005 20250518003839.0
264 0 _c20190823
008 201908s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/s41416-018-0271-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFriedlander, Michael
245 0 0 _aLong-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
_h[electronic resource]
260 _bBritish journal of cancer
_c10 2018
300 _a1075-1085 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBRCA1 Protein
_xgenetics
650 0 4 _aBRCA2 Protein
_xgenetics
650 0 4 _aCapsules
650 0 4 _aCystadenocarcinoma, Serous
_xdrug therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMaintenance Chemotherapy
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPhthalazines
_xadministration & dosage
650 0 4 _aPiperazines
_xadministration & dosage
650 0 4 _aPlatinum
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aMatulonis, Ursula
700 1 _aGourley, Charlie
700 1 _adu Bois, Andreas
700 1 _aVergote, Ignace
700 1 _aRustin, Gordon
700 1 _aScott, Clare
700 1 _aMeier, Werner
700 1 _aShapira-Frommer, Ronnie
700 1 _aSafra, Tamar
700 1 _aMatei, Daniela
700 1 _aShirinkin, Vadim
700 1 _aSelle, Frédéric
700 1 _aFielding, Anitra
700 1 _aLowe, Elizabeth S
700 1 _aMcMurtry, Emma L
700 1 _aSpencer, Stuart
700 1 _aRowe, Philip
700 1 _aMann, Helen
700 1 _aParry, David
700 1 _aLedermann, Jonathan
773 0 _tBritish journal of cancer
_gvol. 119
_gno. 9
_gp. 1075-1085
856 4 0 _uhttps://doi.org/10.1038/s41416-018-0271-y
_zAvailable from publisher's website
999 _c28970467
_d28970467